USP5 and rheumatoid arthritis: Finally, ECAR analysis was used to evaluate glycolytic capacity, showing that TNF-α enhanced glycolysis in RA-FLSs, while USP5 knockdown or 2-DG treatment inhibited this glycolytic activity (Fig. 2H).